# Xeris Biopharma (XERS) — Analyst Forecast

XERS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xers/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 6, 2026 | Barclays | Maintained | Overweight | $14.00 |
| Sep 10, 2026 | Leerink Partners | Maintained | Outperform | $16.00 |
| Aug 20, 2026 | Barclays | Maintained | Overweight | $12.00 |
| Mar 2, 2026 | HC Wainwright & Co. | Maintained | Buy | $10.00 |
| Jan 9, 2026 | HC Wainwright & Co. | Maintained | Buy | $10.00 |
| Dec 9, 2025 | Barclays | Initiated Coverage | Overweight | $9.00 |
| Nov 7, 2025 | Piper Sandler | Maintained | Neutral | $8.00 |
| Nov 7, 2025 | Oppenheimer | Maintained | Outperform | $18.00 |
| Nov 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $10.00 |
| Oct 29, 2025 | Oppenheimer | Maintained | Outperform | $18.00 |
| Aug 19, 2025 | Leerink Partners | Maintained | Outperform | $9.00 |
| Aug 12, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $10.00 |
| May 9, 2025 | Oppenheimer | Maintained | Outperform | $7.00 |
| Mar 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Mar 7, 2025 | Piper Sandler | Maintained | Neutral | $4.00 |
| Mar 7, 2025 | Craig-Hallum | Maintained | Buy | $6.50 |
| Mar 7, 2025 | Leerink Partners | Maintained | Outperform | $6.00 |
| Jan 29, 2025 | Jefferies | Maintained | Buy | $6.00 |
| Nov 11, 2024 | Piper Sandler | Downgraded | Overweight → Neutral | $3.00 |
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | $6.60 |

## Frequently Asked Questions

### What is the latest analyst rating on XERS?

On Oct 6, 2026, Barclays maintained Xeris Biopharma at Overweight with a price target of $14.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).